MDVL Insider Trading Activity and SEC Form 4 Filings
MDVL insider trading summary
No open-market insider purchases or sales of MedAvail Holdings, Inc. (MDVL) have been reported on SEC Form 4 in the past 12 months.
Latest MDVL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 28, 2023 | Ramona Seabaugh | Chief Financial Officer | Sell | $2K (303 @ $5.70) |
| Mar 21, 2023 | Ramona Seabaugh | Chief Financial Officer | Sell | $1K (3,287 @ $0.31) |
| Mar 6, 2023 | Mark Edward Doerr | Chief Executive Officer | Sell | $23K (72,785 @ $0.31) |
| Mar 3, 2023 | Ramona Seabaugh | Chief Financial Officer | Sell | $2K (6,727 @ $0.34) |
| Mar 3, 2023 | Mark Edward Doerr | Chief Executive Officer | Sell | $7K (20,773 @ $0.33) |
| Apr 4, 2022 | ABG-WTT Global Life Science Capital Partners GP, L.P. | 10% Owner | Buy | $11.8M (11,143,529 @ $1.06) |
| Apr 4, 2022 | ABG-WTT Global Life Science Capital Partners GP Ltd | 10% Owner | Buy | $11.8M (11,143,529 @ $1.06) |
| Apr 4, 2022 | ABG WTT-MedAvail Ltd | 10% Owner | Buy | $11.8M (11,143,529 @ $1.06) |
| Apr 4, 2022 | Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. | 10% Owner | Buy | $11.8M (11,143,529 @ $1.06) |
| Apr 4, 2022 | ABG Management Ltd. | 10% Owner | Buy | $11.8M (11,143,529 @ $1.06) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.